Multiple Myeloma

Yelak Biru, who was diagnosed with multiple myeloma at age 25, shares his inspiring story, including the top 3 lessons that helped him remain positive. Read More ›

Saying a few good words about cancer may seem a daunting task. However, lately it has occurred to me that my journey with cancer has some bright spots. It all began on March 17, 2014. The day you learn you might have cancer is a date you never forget. Read More ›

In February 2017, the FDA approved the oral drug Revlimid (lenalidomide) for maintenance (continuing) therapy for patients with multiple myeloma who had autologous hematopoietic stem-cell transplant. Revlimid was previously approved for multiple myeloma and for other types of cancer. Read More ›

March is multiple myeloma month. Check out our slideshow on this cancer type. Read More ›

Despite the great advances in cancer therapies, only a small proportion of patients with cancer participate in clinical trials today. This has a detrimental effect on the development of new cancer drugs. Read More ›

It’s quite common for patients with cancer to form strong bonds with their oncologists. But it’s not often that patients form connections with researchers, the very scientists who develop cancer therapies that help patients, especially patients facing cancer. Read More ›

The death-defying feats of James Bond were explored on an episode of the Lifetime network’s The Balancing Act. No, not that James Bond. Our James Bond didn’t hail from the UK’s Secret Service, but is an American who has been besieged by a foe as lethal as Dr. No or SMERSH–the rare blood cancer multiple myeloma. Read More ›

Multiple myeloma is a type of blood cancer; the cause of this cancer is not yet known. Although it is not considered a hereditary cancer and does not run in families, many genetic factors, especially genetic alterations (mutations) and chromosome abnormalities, play a role in multiple myeloma, as in many other cancers. Read More ›

Multiple myeloma is a rare blood cancer that causes white blood cells to over produce, preventing healthy blood cells to grow in the bone marrow. The abnormal cells develop into cancerous cells that affect the kidneys and other organs, and lead to bone problems and infections. Read More ›

Multiple myeloma is a relatively uncommon blood cancer primarily affecting the blood, bone marrow, and lymph nodes, and may sometimes create an actual tumor. Read More ›